Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Nutrition US Sales Grow: Health And Wellness Industry News Roundup

This article is powered by The Rose Sheet

Executive Summary

Organic Trade Association urges FTC to issue guidance to makers of non-food products making organic claims; Ritual adds funding, begins sales; and more news in brief.

You may also be interested in...



Cosmetics News In Brief: FTC ‘Organic’ Roundtable; Coty Buys ghd; Avon ‘Boss Life’; More

Industry and NGO reps will join FTC and the USDA October 20 to discuss how consumers perceive “organic” claims on non-agricultural products, such as cosmetics. In other news, Coty acquires pro hair-care brand ghd (Good Hair Day), and Avon launches a campaign to drive sales rep recruitment in North America.

Probiotics Sales Boom Grows On Beverages, Children’s Products

Beverages are the fastest-growing probiotics category in the US, with a slew of teas, juices and powder mixes introduced to meet consumer demand, announces Ganeden Biotech, which supplied its GanedenBC30 organism for 75 probiotic SKUs recently launched.

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS108639

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel